A clinical study of CL2020 in patients with spinal cord injury
Phase 2
Completed
- Conditions
- spinal cord injury
- Registration Number
- JPRN-jRCT1080224764
- Lead Sponsor
- ife Science Institute Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Patients with cervical spinal cord injury within 2weeks of injury
Severity of modified Frankel classification grade B1 or B2
Patients with Neurological level of injury between C4 and C7
Exclusion Criteria
Patients with any existing or previous malignant tumor
Female patients who are or may be pregnant or who are breastfeeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy<br>efficacy after infusion of CL2020
- Secondary Outcome Measures
Name Time Method safety<br>safety after infusion of CL2020